Dr. Miguel Quiros did his undergrad studies in microbiology at the University of Costa Rica. He obtained his PhD in Molecular and Cellular Physiology at the Center for Research and Advanced Studies in Mexico City, Mexico. During his PhD he specialized in epithelial cell junctions and their physiological regulation. His research focuses on the resolution phase of intestinal inflammation. His current projects include: (a) establishing a defined matrix to grow mini-guts with the potential to be engrafted into ulcerated tissue from IBD patients and promote epithelial recovery; (b) characterizing the kinetics of cytokine release during the resolution phase of inflammation and describe the cascade of events that lead to recovery of homeostasis; (c) studying the effect of specialized pro-resolution mediators on intestinal epithelial wound healing. Dr. Quiros was awarded with the CCFA 2016 Shanti Sitaraman, MD, PhD, Young IBD Investigator Award for his research on the role of Resolvin E1 on intestinal epithelial wound healing.
